These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29330805)

  • 1. In Vitro Assays of Breast Cancer Stem Cells.
    Samanta D; Semenza GL
    Methods Mol Biol; 2018; 1742():237-246. PubMed ID: 29330805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of tumor-initiating breast cancer cells within a mammosphere-culture microdevice.
    Saadin K; Burke JM; Patel NP; Zubajlo RE; White IM
    Biomed Microdevices; 2013 Aug; 15(4):645-655. PubMed ID: 23515914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
    Farnie G; Sotgia F; Lisanti MP
    Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
    Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
    Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
    Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G
    Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions.
    Iriondo O; Rábano M; Domenici G; Carlevaris O; López-Ruiz JA; Zabalza I; Berra E; Vivanco Md
    Oncotarget; 2015 Oct; 6(31):31721-39. PubMed ID: 26372732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture.
    Rodríguez CE; Berardi DE; Abrigo M; Todaro LB; Bal de Kier Joffé ED; Fiszman GL
    J Cell Biochem; 2018 Feb; 119(2):1381-1391. PubMed ID: 28722778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog
    Zhang X; Li F; Zheng Y; Wang X; Wang K; Yu Y; Zhao H
    Oxid Med Cell Longev; 2019; 2019():9078209. PubMed ID: 30906504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
    Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
    Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unravelling the Therapeutic Potential of Antibiotics in Hypoxia in a Breast Cancer MCF-7 Cell Line Model.
    Akhunzianov AA; Nesterova AI; Wanrooij S; Filina YV; Rizvanov AA; Miftakhova RR
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
    Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
    Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Renewal and CSCs In Vitro Enrichment: Growth as Floating Spheres.
    Mehta P; Novak C; Raghavan S; Ward M; Mehta G
    Methods Mol Biol; 2018; 1692():61-75. PubMed ID: 28986887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
    Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
    Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxycycline targets aldehyde dehydrogenase‑positive breast cancer stem cells.
    Lin CC; Lo MC; Moody RR; Stevers NO; Tinsley SL; Sun D
    Oncol Rep; 2018 Jun; 39(6):3041-3047. PubMed ID: 29620216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells--an in vitro and in silico study.
    Pandrangi SL; Chikati R; Chauhan PS; Kumar CS; Banarji A; Saxena S
    Tumour Biol; 2014 Jan; 35(1):723-37. PubMed ID: 23982874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced secretion stimulates breast cancer stem cell regulatory signalling pathways.
    Jacobsson H; Harrison H; Hughes É; Persson E; Rhost S; Fitzpatrick P; Gustafsson A; Andersson D; Gregersson P; Magnusson Y; Ståhlberg A; Landberg G
    Mol Oncol; 2019 Aug; 13(8):1693-1705. PubMed ID: 31066211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells.
    López-Mateo I; Alonso-Merino E; Suarez-Cabrera C; Park JW; Cheng SY; Alemany S; Paramio JM; Aranda A
    Thyroid; 2020 Jan; 30(1):116-132. PubMed ID: 31760908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.